Fibulin-1 inhibits in vitro cell adhesion and motility in a cell- and matrix-specific manner; fibronectin is required for fibulin-1 to suppress cell motility of breast cancer [49,50] and ovarian cancer cells [50]. This evidence concerns the gene FBLN1 and breast cancer.